Stephen L. Dahl

1.0k total citations · 1 hit paper
18 papers, 812 citations indexed

About

Stephen L. Dahl is a scholar working on Rheumatology, Pharmacology and Pharmacology. According to data from OpenAlex, Stephen L. Dahl has authored 18 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Rheumatology, 5 papers in Pharmacology and 3 papers in Pharmacology. Recurrent topics in Stephen L. Dahl's work include Rheumatoid Arthritis Research and Therapies (7 papers), Systemic Lupus Erythematosus Research (4 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Stephen L. Dahl is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (7 papers), Systemic Lupus Erythematosus Research (4 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Stephen L. Dahl collaborates with scholars based in United States, Canada and Denmark. Stephen L. Dahl's co-authors include John Ward, H. James Williams, Cecil O. Samuelson, Kim M. Murray, Marlene J. Egger, James C. Reading, Michael E. Luggen, Robert F. Willkens, Maria Guttadauria and Graciela S. Alarcón and has published in prestigious journals such as The American Journal of Medicine, Cephalalgia and Seminars in Arthritis and Rheumatism.

In The Last Decade

Stephen L. Dahl

18 papers receiving 748 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparison of low‐dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A Controlled Clinical Trial

1985 382 citations H. James Williams, Robert F. Willkens et al. Arthritis & Rheumatism profile →

Peers

Stephen L. Dahl

RHEUM

HEMAT

IMMUN

GENET

PFM

A. P. Crockson United Kingdom

M F Martin United Kingdom

Glenn Tisman United States

Alexandra McFarlane Canada

L Trang Sweden

Collette McCourt United Kingdom

P. B. B. Jones New Zealand

Tara Starnino Canada

Vincent Richer Canada

Y Matsuzawa Japan

A. P. Crockson United Kingdom

Stephen L. Dahl

424 ×1.0

RHEUM

119 ×0.6

HEMAT

94 ×0.7

IMMUN

54 ×0.4

GENET

24 ×0.2

PFM

Citations per year, relative to Stephen L. Dahl Stephen L. Dahl (= 1×) peers A. P. Crockson

Countries citing papers authored by Stephen L. Dahl

Since Specialization

Citations

This map shows the geographic impact of Stephen L. Dahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen L. Dahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen L. Dahl more than expected).

Fields of papers citing papers by Stephen L. Dahl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen L. Dahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen L. Dahl. The network helps show where Stephen L. Dahl may publish in the future.

Co-authorship network of co-authors of Stephen L. Dahl

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen L. Dahl. A scholar is included among the top collaborators of Stephen L. Dahl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen L. Dahl. Stephen L. Dahl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Lower‐Hoppe, Leeann M., et al.. (2020). How Do Collegiate Sport Clubs Achieve Organizational Effectiveness?. 1 indexed citations

Murray, Kim M. & Stephen L. Dahl. (1997). Recombinant Human Tumor Necrosis Factor Receptor (P75) Fc Fusion Protein (Tnfr: Fc) in Rheumatoid Arthritis. Annals of Pharmacotherapy. 31(11). 1335–1338. 70 indexed citations

Dahl, Stephen L.. (1995). Advances and issues in the pharmacotherapy of rheumatoid arthritis. Journal of Clinical Pharmacy and Therapeutics. 20(3). 131–147. 1 indexed citations

Myrhøj, T, Inge Bernstein, Marie Luise Bisgaard, et al.. (1994). The establishment of an HNPCC register.. PubMed. 14(4B). 1647–50. 12 indexed citations

Dahl, Stephen L.. (1993). Nabumetone: A “Nonacidic” Nonsteroidal Antiinflammatory Drug. Annals of Pharmacotherapy. 27(4). 456–463. 21 indexed citations

Isley, William L., Stephen L. Dahl, & Harry Gibbs. (1990). Use of esmolol in managing a thyrotoxic patient needing emergency surgery. The American Journal of Medicine. 89(1). 122–123. 27 indexed citations

Dahl, Stephen L., et al.. (1990). Second‐Line Antirheumatic Drugs in the Elderly with Rheumatoid Arthritis: A Post Hoc Analysis of Three Controlled Trials. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 10(2). 79–84. 33 indexed citations

Williams, H. James, John Ward, Stephen L. Dahl, et al.. (1988). A controlled trial comparing sulfasalazine, gold sodium thiomalate, and placebo in rheumatoid arthritis. Arthritis & Rheumatism. 31(6). 702–713. 89 indexed citations

Williams, H. James, Stephen L. Dahl, John Ward, et al.. (1988). One‐year experience in patients treated with auranofin following completion of a parallel, controlled trial comparing auranofin, gold sodium thiomalate, and placebo. Arthritis & Rheumatism. 31(1). 9–14. 9 indexed citations

10.

Clegg, Daniel O., Joe G. Hardin, John H. Klippel, et al.. (1987). Lack of association between hla–dr2 and clinical response to methotrexate in patients with rheumatoid arthritis. Arthritis & Rheumatism. 30(2). 218–220. 6 indexed citations

11.

Dahl, Stephen L. & John Ward. (1986). Efficacy and tolerability of oxaprozin in the elderly. Seminars in Arthritis and Rheumatism. 15(3). 40–46. 6 indexed citations

12.

Dahl, Stephen L., et al.. (1986). The Effect of Cimetidine on Serum Concentrations of Piroxicam. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 6(3). 112–117. 9 indexed citations

13.

Williams, H. James, Daniel E. Furst, Stephen L. Dahl, et al.. (1985). Double‐blind, multicenter controlled trial comparing topical dimethyl sulfoxide and normal saline for treatment of hand ulcers in patients with systemic sclerosis. Arthritis & Rheumatism. 28(3). 308–314. 32 indexed citations

14.

Dahl, Stephen L., Miki L. Coleman, H. James Williams, et al.. (1985). Lack of correlation between blood gold concentrations and clinical response in patients with definite or classic rheumatoid arthritis receiving auranofin or gold sodium thiomalate. Arthritis & Rheumatism. 28(11). 1211–1218. 24 indexed citations

15.

Williams, H. James, Robert F. Willkens, Cecil O. Samuelson, et al.. (1985). Comparison of low‐dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A Controlled Clinical Trial. Arthritis & Rheumatism. 28(7). 721–730. 382 indexed citations breakdown →

16.

Dahl, Stephen L., et al.. (1983). Prophylactic Treatment of Classical and Non-Classical Migraine With Metoprolol—a Comparison with Placebo. Cephalalgia. 3(4). 207–212. 51 indexed citations

17.

Dahl, Stephen L. & John Ward. (1982). Pharmacology, Clinical Efficacy, and Adverse Effects of the Nonsteroidal Anti‐Inflammatory Agent Benoxaprofen. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 2(6). 354–365. 19 indexed citations

18.

Dahl, Stephen L. & John Ward. (1982). Pharmacology, Clinical Efficacy, and Adverse Effects of Piroxicam, A New Nonsteroidal Anti‐Inflammatory Agent. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 2(2). 80–90. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact